During the past decade, Hospital Clinico Universitario de Santiago conducted 316 clinical trials. In the 10-year time frame, 316 clinical trials started and 106 clinical trials were completed, i.e. on average, 33.5% percent of trials that started reached the finish line to date. In the past 5 years, 159 clinical trials started and 67 clinical trials were completed. i.e. 42.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clinico Universitario de Santiago" #1 sponsor was "Pfizer" with 32 trials, followed by "PETHEMA Foundation" with 28 trials sponsored, "Janssen Research & Development, LLC" with 15 trials sponsored, "Boehringer Ingelheim" with 13 trials sponsored and "Celgene" with 13 trials sponsored. Other sponsors include 344 different institutions and companies that sponsored additional 209 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clinico Universitario de Santiago" #1 collaborator was "Eli Lilly and Company" with 7 trials as a collaborator, "Hospital Clinico Universitario de Santiago" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator and "Novartis" with 5 trials as a collaborator. Other collaborators include 241 different institutions and companies that were collaborators in the rest 204 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clinico Universitario de Santiago" are "Multiple Myeloma" (18 trials), "Breast Cancer" (14 trials), "Coronary Artery Disease" (14 trials), "Rheumatoid Arthritis" (9 trials) and "Heart Failure" (8 trials). Many other conditions were trialed in "Hospital Clinico Universitario de Santiago" in a lesser frequency.

Most popular intervention types in "Hospital Clinico Universitario de Santiago" are "Drug" (319 trials), "Other" (50 trials), "Device" (36 trials), "Biological" (29 trials) and "Procedure" (23 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (89 trials), "Dexamethasone" (17 trials), "Prednisone" (9 trials), "Bortezomib" (8 trials) and "Cyclophosphamide" (8 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clinico Universitario de Santiago" are 408 trials for "All" genders, 26 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are 160 active trials in "Hospital Clinico Universitario de Santiago". 3 are not yet recruiting, 84 are recruiting, 70 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 214 completed trials in Hospital Clinico Universitario de Santiago, 1 suspended trials, and 45 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clinico Universitario de Santiago, 22 "Phase 1" clinical trials were conducted, 115 "Phase 2" clinical trials and 165 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 43 trials, and there were also 25 trials that are defined as “Not Applicable".